Survival after implantable cardioverter-defibrillator implantation in the elderly

Circulation

Volumn 127, Issue 24, 2013, Pages 2383-2392

  Yung, Derek ^a,b   Birnie, David ^b   Dorian, Paul ^c   Healey, Jeffrey S ^d   Simpson, Christopher S ^e   Crystal, Eugene ^a   Krahn, Andrew D ^f   Khaykin, Yaariv ^g   Cameron, Douglas ^h   Chen, Zhongliang ^a   Lee, Douglas S ^a,h  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

^c ST MICHAEL'S HOSPITAL   (Canada)

^d MCMASTER UNIVERSITY   (Canada)

^e QUEEN S UNIVERSITY   (Canada)

^f UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^g SOUTHLAKE REGIONAL HEALTH CENTRE   (Canada)

^h UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

Aged; Defibrillators; Implantabale; Prognosis; Prospective studies; Registries

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANADA; CARDIOVASCULAR MORTALITY; FEMALE; GROUPS BY AGE; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIMARY PREVENTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; SECONDARY PREVENTION; SHOCK;

AGED; DEFIBRILLATORS, IMPLANTABALE; PROGNOSIS; PROSPECTIVE STUDIES; REGISTRIES;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ARRHYTHMIAS, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; FEMALE; HUMANS; MALE; MIDDLE AGED; ONTARIO; PRIMARY PREVENTION; PROSPECTIVE STUDIES; REGISTRIES; RETROSPECTIVE STUDIES; SECONDARY PREVENTION; SURVIVAL RATE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84879318184     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.113.001442     Document Type: Article

References (36)

1. Epstein AE, DiMarco JP, Ellenbogen K.A., Estes NA III, Freedman RA, Gettes LS, Gillinov AM, Gregoratos G, Hammill SC, Hayes DL, Hlatky MA, Newby LK, Page RL, Schoenfeld MH, Silka MJ, Stevenson LW, Sweeney MO, Smith SC Jr, Jacobs AK, Adams CD, Anderson JL, Buller CE, Creager MA, Ettinger SM, Faxon DP, Halperin JL, Hiratzka LF, Hunt SA, Krumholz HM, Kushner FG, Lytle BW, Nishimura RA, Ornato JP, Page RL, Riegel B, Tarkington LG, Yancy CW. ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. Circulation. 2008; 117:e350-e408.
2. Ruskin JN, Camm AJ, Zipes D.P., Hallstrom AP, McGrory-Usset ME. Implantable cardioverter defibrillator utilization based on discharge diagnoses from Medicare and managed care patients. J Cardiovasc Electro-physiol. 2002;13:38-43.
3. Lee DS, Tu JV, Austin P.C., Dorian P., Yee R, Chong A, Alter D.A., Laupacis A. Effect of cardiac and noncardiac conditions on survival after defibrillator implantation. J Am Coll Cardiol. 2007;49:2408-2415.
4. Krahn AD, Connolly SJ, Roberts R.S., Gent M; ATMA Investigators. Diminishing proportional risk of sudden death with advancing age: implications for prevention of sudden death. Am Heart J. 2004;147:837-840.
5. Hunt SA, Abraham WT, Chin M.H., Feldman AM, Francis GS, Ganiats TG, Jessup M, Konstam M.A., Mancini DM, Michl K, Oates JA, Rahko P.S., Silver MA, Stevenson LW, Yancy CW 2009 Focused update incorporated into the ACC/AHA 2005 guidelines for the diagnosis and management of heart failure in adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation. 2009;119:e391-e479.
6. Dickstein K, Vardas PE, Auricchio A, Daubert J.C., Linde C., McMurray J, Ponikowski P, Priori S.G., Sutton R., van Veldhuisen DJ, Vahanian A, Auricchio A, Bax J., Ceconi C, Dean V, Filippatos G., Funck-Brentano C, Hobbs R, Kearney P., McDonagh T, Popescu BA, Reiner Z, Sechtem U., Sirnes PA, Tendera M, Vardas P, Widimsky P, Tendera M, Anker SD, Blanc JJ, Gasparini M, Hoes AW, Israel CW, Kalarus Z, Merkely B, Swedberg K, Camm AJ. 2010 Focused update of ESC guidelines on device therapy in heart failure: an update of the 2008 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC guidelines for cardiac and resynchronization therapy; developed with the special contribution of the Heart Failure Association and the European Heart Rhythm Association. Eur Heart J. 2010;31:2677-87.
7. Lee DS, Birnie D, Cameron D., Crystal E, Dorian P, Gula L.J., Healey JS, Janmohammed A, Khaykin Y, Krahn A.D., LeFeuvre C., Simpson CS, Yee R, Hardy J, Slaughter P.M., Chen Z., Alter DA, Laupacis A, Tu JV; Population-Based Registry of Implantable Cardioverter Defibrillators. Design and implementation of a population-based registry of implantable car-dioverter defibrillators (ICDs) in Ontario. Heart Rhythm. 2008;5:1250-1256.
8. MacFadden DR, Crystal E, Krahn A.D., Mangat I., Healey JS, Dorian P, Birnie D, Simpson C.S., Khaykin Y., Pinter A, Nanthakumar K, Calzavara A.J., Austin PC, Tu J V, Lee DS Sex differences in implantable cardioverter- defibrillator outcomes: findings from a prospective defibrillator database. Ann Intern Med. 2012;156:195-203.
9. Gould PA, Krahn AD; Canadian Heart Rhythm Society Working Group on Device Advisories. Complications associated with implantable cardio-verter- defibrillator replacement in response to device advisories. JAMA. 2006;295:1907-1911.
10. Krahn AD, Lee DS, Birnie D, Healey J.S., Crystal E., Dorian P, Simpson CS, Khaykin Y, Cameron D., Janmohamed A, Yee R, Austin P.C., Chen Z., Hardy J, Tu JV; Ontario ICD Database Investigators. Predictors of short-term complications after implantable cardioverter-defibrillator replacement: results from the Ontario ICD Database. Circ Arrhythm Electrophysiol. 2011;4:136-142.
11. Lee DS, Krahn AD, Healey J.S., Birnie D., Crystal E, Dorian P, Simpson C.S., Khaykin Y., Cameron D, Janmohamed A, Yee R., Austin PC, Chen Z, Hardy J, Tu JV; Investigators of the Ontario ICD Database. Evaluation of early complications related to de novo cardioverter defibrillator implantation insights from the Ontario ICD database. J Am Coll Cardiol. 2010;55:774-782.
12. Harrell FEJ. Regression Modeling Strategies. New York, NY: Springer Verlag; 2001.
13. Levey AS, Coresh J, Greene T., Stevens LA, Zhang YL, Hendriksen S, Kusek J.W., Van Lente F; Chronic Kidney Disease Epidemiology Collaboration. Using standardized serum creatinine values in the Modification of Diet in Renal Disease study equation for estimating glomerular filtration rate. Ann Intern Med. 2006;145:247-254.
14. Fine JP, Gray RJ A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc. 1999; 94:496-509.
15. Healey JS, Hallstrom AP, Kuck K.H., Nair G., Schron EP, Roberts RS, Morillo CA, Connolly SJ Role of the implantable defibrillator among elderly patients with a history of life-threatening ventricular arrhythmias. Eur Heart J. 2007;28:1746-1749.
16. Santangeli P, Di Biase L, Dello Russo A, Casella M, Bartoletti S., Santarelli P, Pelargonio G, Natale A. Meta-analysis: age and effectiveness of prophylactic implantable cardioverter-defibrillators. Ann Intern Med. 2010;153:592-599.
17. Huang DT, Sesselberg HW, McNitt S, Noyes K., Andrews ML, Hall WJ, Dick A, Daubert J.P., Zareba W., Moss AJ; MADIT-II Research Group. Improved survival associated with prophylactic implantable defibrilla-tors in elderly patients with prior myocardial infarction and depressed ventricular function: a MADIT-II substudy. J Cardiovasc Electrophysiol. 2007;18:833-838.
18. Bardy GH, Lee KL, Mark D.B., Poole JE, Packer DL, Boineau R, Domanski M., Troutman C, Anderson J, Johnson G., McNulty SE, Clapp-Channing N, Davidson-Ray LD, Fraulo E.S., Fishbein DP, Luceri RM, Ip JH; Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators. Amioda-rone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med. 2005;352:225-237.
19. Bristow MR, Saxon LA, Boehmer J, Krueger S., Kass DA, De Marco T, Carson P, DiCarlo L., DeMets D, White BG, DeVries D.W., Feldman AM; Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Investigators. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med. 2004;350:2140-2150.
20. Tsai V, Goldstein MK, Hsia H.H., Wang Y., Curtis J, Heidenreich PA; National Cardiovascular Data Registry. Age differences in primary prevention implantable cardioverter-defibrillator use in U.S. individuals. J Am Geriatr Soc. 2011;59:1589-1595.
21. Epstein AE, Kay GN, Plumb V.J., McElderry HT, Doppalapudi H, Yamada T, Shafiroff J., Syed ZA, Shkurovich S; ACT Investigators. Implantable cardioverter-defibrillator prescription in the elderly. Heart Rhythm. 2009;6:1136-1143.
22. Chan PS, Nallamothu BK, Spertus J.A., Masoudi FA, Bartone C, Kereiakes DJ, Chow T. Impact of age and medical comorbidity on the effectiveness of implantable cardioverter-defibrillators for primary prevention. Circ Cardiovasc Qual Outcomes. 2009;2:16-24.
23. Koplan BA, Epstein LM, Albert C.M., Stevenson WG Survival in octogenarians receiving implantable defibrillators. Am Heart J. 2006;152:714-719.
24. Grimm W, Stula A, Sharkova J., Alter P, Maisch B. Outcomes of elderly recipients of implantable cardioverter defibrillators. Pacing Clin Electrophysiol. 2007;30(suppl 1):S134-S138.
25. Ermis C, Zhu AX, Vanheel L, Sakaguchi R.N., Lurie KG, Lu F, Benditt DG Comparison of ventricular arrhythmia burden, therapeutic interventions, and survival, in patients < 75 and patients >or= 75 years of age treated with implantable cardioverter defibrillators. Europace. 2007;9:270-274.
26. Hohnloser SH, Kuck KH, Dorian P, Roberts R.S., Hampton JR, Hatala R, Fain E, Gent M., Connolly SJ; DINAMIT Investigators. Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction. N Engl J Med. 2004;351:2481-2488.
27. Moss AJ, Zareba W, Hall W.J., Klein H., Wilber DJ, Cannom DS, Daubert JP, Higgins S.L., Brown MW, Andrews ML; Multicenter Automatic Defibrillator Implantation Trial II Investigators. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 2002;346:877-883.
28. The Antiarrhythmics Versus Implantable Defibrillators (AVID) Investigators. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med. 1997;337:1576-1583.
29. Connolly SJ, Gent M, Roberts R.S., Dorian P., Roy D, Sheldon RS, Mitchell L.B., Green MS, Klein GJ, O'Brien B. Canadian Implantable Defibrillator Study (CIDS): a randomized trial of the implantable cardioverter defibrillator against amiodarone. Circulation. 2000;101:1297-1302. honoraria from Bayer and Bristol-Myers Squibb. Dr Khaykin has received speaker's fees and honoraria from Bayer, Boehringer Ingelheim, Servier, Medtronic, and Biosense Webster. The other authors report no conflicts.
30. Klein RC, Raitt MH, Wilkoff B.L., Beckman KJ, Coromilas J, Wyse DG, Friedman P.L., Martins JB, Epstein AE, Hallstrom AP, Ledingham R.B., Belco KM, Greene HL; AVID Investigators. Analysis of implantable cardioverter defibrillator therapy in the Antiarrhythmics Versus Implantable Defibrillators (AVID) Trial. J Cardiovasc Electrophysiol. 2003;14:940-948.
31. Mitchell LB, Pineda EA, Titus J.L., Bartosch PM, Benditt DG Sudden death in patients with implantable cardioverter defibrillators: the importance of post-shock electromechanical dissociation. J Am Coll Cardiol. 2002;39:1323-1328.
32. van Rees J.B., Borleffs CJ, de Bie MK, Stijnen T, van Erven L, Bax JJ, Schalij MJ Inappropriate implantable cardioverter-defibrillator shocks: incidence, predictors, and impact on mortality. J Am Coll Cardiol. 2011;57:556-562.
33. Germano JJ, Reynolds M, Essebag V., Josephson ME Frequency and causes of implantable cardioverter-defibrillator therapies: is device therapy proarrhythmic? Am J Cardiol. 2006;97:1255-1261.
34. Daubert JP, Zareba W, Cannom D.S., McNitt S., Rosero SZ, Wang P, Schuger C, Steinberg J.S., Higgins SL, Wilber DJ, Klein H, Andrews M.L., Hall WJ, Moss AJ; MADIT II Investigators. Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: frequency, mechanisms, predictors, and survival impact. J Am Coll Cardiol. 2008;51:1357-1365.
35. Goldenberg I, Vyas AK, Hall W.J., Moss AJ, Wang H, He H, Zareba W., McNitt S, Andrews ML; MADIT-II Investigators. Risk stratification for primary implantation of a cardioverter-defibrillator in patients with ischemic left ventricular dysfunction. J Am Coll Cardiol. 2008;51:288-296.
36. Buxton AE, Lee KL, Hafley G.E., Pires LA, Fisher JD, Gold MR, Josephson M.E., Lehmann MH, Prystowsky EN; MUSTT Investigators. Limitations of ejection fraction for prediction of sudden death risk in patients with coronary artery disease: lessons from the MUSTT study. J Am Coll Cardiol. 2007;50:1150-1157.